OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
September 13, 2023
Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.
September 12, 2023
How drugmakers can navigate the program’s pricing challenges and regulatory developments.
August 24, 2023
Expansion allows facility to provide E2E services in one location, including commercial manufacturing.
August 10, 2023
The company will occupy approximately 62,000 square feet of the new building.
August 09, 2023
The plant— dedicated to cell and gene therapy development—welcomes additional warehouse space, and aims to meet commercial needs.
August 07, 2023
How the ‘fight-for-the-dollar’ is coming and likely will impact the bundled pricing of industry stakeholders.
August 04, 2023
Companies' emphasis on delivering pharmaceuticals is evolving into a collaboration focused on healthcare outcomes.
The key questions and considerations for drug manufacturers pursuing an effective alternative distribution model.
August 02, 2023
CDMO’s Taoyuan City plant is set to provide customers with products ranging from emulsions to gels.
July 28, 2023
CDMO’s Turku addition will span over 69,000 square feet and support the production of ATMPs.